Structuring and preparation method of Ad5-M2m used as general influenza vaccine virus seed
Patent Information
- Authority / Receiving Office
- CN ยท China
- Current Assignee / Owner
- SOUTH CHINA AGRI UNIV
- Publication Date
- 2017-03-08
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of vaccine preparation, in particular to a method for constructing and preparing Ad5-M2m recombinant adenovirus as a universal influenza vaccine virus seed by using a genetic engineering method. Background technique
[0002] At present, influenza vaccines are mainly used in the prevention of influenza. The vaccine for avian influenza is mainly an inactivated whole virus vaccine. This vaccine is safe and well tolerated, and can induce a high humoral immune response, but cannot induce effective cellular immune response and mucosal immune response. Immune response, and the incidence of adverse reactions during the vaccination process is also high, which affects the egg production rate and meat quality of poultry; at the same time, due to the continuous variation and recombination of avian influenza viruses, it is common that inactivated vaccines cannot cross-protect different branches of the same subtype The ph...